© 2007 American Public Health Association DOI: 10.2105/AJPH.2006.102749
Martin Meyer Weiss is with the Veterans Administration, Sepulveda, Calif, and the School of Medicine, University of California, Los Angeles. Peter D. Weiss is with the School of Medicine, University of California, Los Angeles. Joseph B. Weiss is with the School of Medicine, University of California, San Diego. Correspondence: Requests for reprints should be sent to Martin Meyer Weiss, MD, Veterans Administration, 16111 Plummer St, Sepulveda, CA 91343 (e-mail: martin.weiss{at}med.va.gov).
The Centers for Disease Control and Prevention has classified Bacillus anthracis, the causative organism of anthrax, as a category A potential bioterrorism agent. There are critical shortcomings in the US anthrax vaccine program. Rather than depending on the private sector, the government must assume direct production of anthrax vaccine. The development of a capacity capable of preemptive immunization of the public against anthrax should be considered. This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||